PPL:TSXPembina Pipeline Corporation Analysis
Data as of 2026-03-10 - not real-time
CA$60.66
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Pembina Pipeline is trading at C$60.66, just below its 52‑week high of C$61.81 and comfortably above the 20‑day SMA (C$60.12) and 50‑day SMA (C$56.62), indicating short‑term bullish momentum. However, the MACD histogram is negative and the signal line is bearish, while the RSI sits at 64, suggesting the rally may be losing steam. Volume is on the rise, supporting the current trend, but the stock is priced well above its DCF fair value of roughly C$21.5 and carries a P/E of 22.8 versus an industry average of 20.3, flagging an overvalued condition. The dividend yield is attractive at 4.69% but the payout ratio exceeds 100%, raising concerns about sustainability, especially as revenue has contracted 10.8% year‑over‑year. The balance sheet shows a high debt‑to‑equity of ~79%, though operating cash flow remains strong at C$3.3 bn.
Recent headlines note that PPL has managed to out‑perform the broader market despite modest price drops, and analysts maintain a “Buy” consensus with a median target of C$61.5. This resilience reflects the fee‑based, contract‑heavy nature of its mid‑stream assets, yet the combination of overvaluation, bearish technical signals, and dividend sustainability issues suggests caution in the near term. Investors should watch for price corrections toward the support level around C$57.5 and monitor any improvement in revenue growth or debt reduction before committing additional capital.
Recent headlines note that PPL has managed to out‑perform the broader market despite modest price drops, and analysts maintain a “Buy” consensus with a median target of C$61.5. This resilience reflects the fee‑based, contract‑heavy nature of its mid‑stream assets, yet the combination of overvaluation, bearish technical signals, and dividend sustainability issues suggests caution in the near term. Investors should watch for price corrections toward the support level around C$57.5 and monitor any improvement in revenue growth or debt reduction before committing additional capital.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD divergence
- Price near resistance with limited upside
- Overvaluation relative to DCF and peers
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable fee‑based cash flow
- High dividend yield but unsustainable payout
- Negative revenue growth and elevated debt
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic mid‑stream infrastructure with long‑term contracts
- Potential for price re‑rating if debt is reduced
- Attractive dividend yield if payout ratio improves
Key Metrics & Analysis
Financial Health
Revenue Growth-10.80%
Profit Margin21.78%
P/E Ratio22.8
ROE9.88%
ROA4.38%
Debt/Equity79.36
P/B Ratio2.3
Op. Cash FlowCA$3.3B
Free Cash FlowCA$1.9B
Industry P/E20.3
Technical Analysis
TrendBullish
RSI64.2
SupportCA$57.47
ResistanceCA$61.81
MA 20CA$60.12
MA 50CA$56.62
MA 200CA$53.58
MACDBearish
VolumeIncreasing
Fear & Greed Index76.84
Valuation
Fair ValueCA$21.54
Target PriceCA$60.61
Upside/Downside-0.08%
GradeOvervalued
TypeValue
Dividend Yield4.69%
Risk Assessment
Beta0.29
Volatility15.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.